文献速递眼底病与葡萄膜炎

肠道微生物组在眼病中的作用

The role of the gut microbiome in eye diseases.
PubMed 文献 · Prog Retin Eye Res · 2022-09-06

本文综述肠道微生物组与眼病的关系,聚焦微生物、微生物衍生代谢物与免疫系统的相互作用。全基因组鸟枪法测序研究显示肠道微生物组的组成及功能能力与年龄相关性黄斑变性、视网膜动脉阻塞、中心性浆液性脉络膜视网膜病变和葡萄膜炎相关。

要点

  • 肠道微生物组失调可通过微生物及代谢物易位诱导全身炎症,可能促进眼病发生。
  • 全基因组鸟枪法测序研究显示肠道微生物组组成与年龄相关性黄斑变性、视网膜动脉阻塞、中心性浆液性脉络膜视网膜病变和葡萄膜炎相关。
  • 微生物组、特定微生物衍生代谢物与免疫系统的相互作用可能参与上述眼病发病机制,并指导微生物组干预新疗法的开发。

核心结论

  • 肠道微生物组组成及功能能力与年龄相关性黄斑变性、视网膜动脉阻塞、中心性浆液性脉络膜视网膜病变和葡萄膜炎相关,微生物组、代谢物与免疫系统的相互作用可能参与其发病机制并指导微生物组干预新疗法的开发。

研究设计与样本

  • 本文为综述,汇总当前关于肠道微生物组在眼病中作用的认识,聚焦微生物组、特定微生物衍生代谢物与免疫系统的相互作用。

主要发现

  • 肠道微生物组平衡时与宿主共生并维持肠道稳态,参与营养代谢、抑制病原体和调节免疫功能。
  • 微生物失调通过微生物及其代谢物沿上皮屏障易位诱导全身炎症,可能导致组织破坏并促进多种疾病发生。
  • 全基因组鸟枪法测序研究显示肠道微生物组的组成及相关功能能力与年龄相关性黄斑变性、视网膜动脉阻塞、中心性浆液性脉络膜视网膜病变和葡萄膜炎相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The gut microbiome is a complex ecosystem of microorganisms and their genetic entities colonizing the gastrointestinal tract. When in balanced composition, the gut microbiome is in symbiotic interaction with its host and maintains intestinal homeostasis. It is involved in essential functions such as nutrient metabolism, inhibition of pathogens and regulation of immune function. Through translocation of microbes and their metabolites along the epithelial barrier, microbial dysbiosis induces systemic inflammation that may lead to tissue destruction and promote the onset of various diseases. Using whole-metagenome shotgun sequencing, several studies have shown that the composition and associated functional capacities of the gut microbiome are associated with age-related macular degeneration, retinal artery occlusion, central serous chorioretinopathy and uveitis. In this review, we provide an overview of the current knowledge about the gut microbiome in eye diseases, with a focus on interactions between the microbiome, specific microbial-derived metabolites and the immune system. We explain how these interactions may be involved in the pathogenesis of age-related macular degeneration, retinal artery occlusion, central serous chorioretinopathy and uveitis and guide the development of new therapeutic approaches by microbiome-altering interventions for these diseases.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Zysset-Burri DC, Morandi S, Herzog EL, et al. The role of the gut microbiome in eye diseases. Prog Retin Eye Res. 2022. PMID: 36075807. doi:10.1016/j.preteyeres.2022.101117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。